Experts discuss the challenges of the ongoing cisplatin and carboplatin shortages in the United States and detail how they are adapting in their practices.
Experts from various institutions were interviewed by OncLive® at the 24th Annual International Lung Cancer Congress® about the ongoing platinum chemotherapy shortage in the United States.
SAN DIEGO (BUSINESS WIRE) RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, appointed Rich Heyman, Ph.D. as chair of the board of directors. Dr. Heyman is an accomplished biotechnology veteran with over 25 years of operational experience.